Koçkan, B., Toptaş, T., Atagündüz, I., Tuğlular, A. T., Özer, A., & Akkiprik, M. (2018). Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia. Oncol Lett.
Citação norma ChicagoKoçkan, Betül, Tayfur Toptaş, Işik Atagündüz, Ayşe Tülin Tuğlular, Ayşe Özer, and Mustafa Akkiprik. "Molecular Screening and the Clinical Impacts of BCR-ABL KD Mutations in Patients With Imatinib-resistant Chronic Myeloid Leukemia." Oncol Lett 2018.
Citação norma MLAKoçkan, Betül, et al. "Molecular Screening and the Clinical Impacts of BCR-ABL KD Mutations in Patients With Imatinib-resistant Chronic Myeloid Leukemia." Oncol Lett 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.